Cantitate/Preț
Produs

To America's Health: A Proposal to Reform the Food and Drug Administration: Hoover Institution Press Publication, cartea 482

Autor Henry I. Miller M.D.
en Limba Engleză Paperback – 3 aug 2000
A government monopoly over drug regulation is not sacrosanct. In fact, federal oversight—which vitally affects the availability of drugs to patients in need—is in shambles. The regulatory monopoly of the federal Food and Drug Administration has become, literally, overkill and actually threatens public health. Regulatory reform that introduces competition and incentives to get safe, effective drugs to patients can, however, transform the drug development process and reverse the current upward spiral of time and costs. The public will benefit directly by earlier access to greater numbers of less costly drugs and indirectly by greater robustness and productivity in the pharmaceutical industry.
Citește tot Restrânge

Din seria Hoover Institution Press Publication

Preț: 10721 lei

Nou

Puncte Express: 161

Preț estimativ în valută:
2052 2129$ 1715£

Carte indisponibilă temporar

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780817999025
ISBN-10: 0817999027
Pagini: 112
Dimensiuni: 154 x 230 x 9 mm
Greutate: 0.24 kg
Editura: Hoover Institution Press
Colecția Hoover Institution Press
Seriile Hoover Institution Press Publication, Hoover Institution Press Publication (Paperback)


Recenzii

"Extraordinary for its depth, documentation, and originality. In terms of analyzing the current system of drug regulation, making the case for reform, and proposing a remedy, this volume simply dwarfs everything else available on the subject. Most important of all, it really does move us along the path 'To America's Health!'"
- Michael H. Mellon, M.D., Associate Clinical Professor, Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA

Notă biografică

Henry I. Miller, M.S., M.D., is a research fellow at the Hoover Institution. His research focuses on public policy toward science and technology, especially pharmaceutical development and the new biotechnology. His work often emphasizes the excessive costs of government regulation and models for regulatory reform.

Descriere

A government monopoly over drug regulation is not sacrosanct. This hard-hitting book describes the current regulation of drugs by the FDA and proposes a model for fundamental, yet workable, reform—including an innovative proposal for drug testing and certification review.